Skip to main content
. Author manuscript; available in PMC: 2013 Jul 24.
Published in final edited form as: Cancer Cell. 2012 Jun 12;21(6):836–847. doi: 10.1016/j.ccr.2012.04.024

Figure 5. Engraftment of GM-CSF knock-down KrasG12D-PDEC is accompanied by an increase in infiltrating CD8+ T cells.

Figure 5

(A) Immunohistochemical staining and quantification of CD8 and cleaved caspase 3 staining on sections of scr- and GM-sh GFP-KrasG12D-PDEC orthotopic grafts at 2 weeks post-implantation. CD8+ or cleaved caspase3-positive cells within the boundaries of orthotopic grafts were counted per field of view (FOV) at 20x magnification. White arrowheads indicate CD8+ cells; black arrowheads indicate caspase-3-positive cells. Scale bars, 50μm. Error bars indicate SD, (n = 4 mice per group, 4 FOV per mouse).

(B) Immunohistochemical staining for CD8 and B220 on consecutive sections of scr- and GM-sh GFP-KrasG12D-PDEC orthotopic grafts at 4 weeks post-implantation. Numbers of CD8+ cells were counted per field of view (FOV) at 20x magnification and are shown in the graph. Arrows indicate co-aggregation of CD8+ cells and B220+ cells. Scale bar, 100μm. Error bars indicate SD, (n = 3 mice per group, 5 FOV per mouse). p value: ***<0.001. See also Figure S4.